Skip to main content
Item(s) Added to Cart

0 item(s) Subtotal $0,00


Oncology Nutrition 2022 Symposium: Advances and Trends in Oncology Nutrition - Research Focus

Come learn about cutting edge oncology nutrition from the leading experts in the field. This bundle of sessions is focused on the topic of Research.

Member Price $69.00

Nonmember Price $79.00


This symposium was hosted live on June 10 - 12, 2022.

Come learn about cutting edge oncology nutrition from the leading experts in the field. This bundle of sessions is focused on the topic of Research.

Change in Malnutrition Risk and Sarcopenia in Radiation Treated Head and Neck Cancer Patients

Inconsistent malnutrition screening practices have contributed to a poor understanding of malnutrition risk among head and neck cancer patients receiving outpatient curative radiotherapy. These patients are not only at increased risk for malnutrition, but emerging evidence indicates they also suffer skeletal muscle loss (sarcopenia). Both the decline in nutritional status and the loss of muscle status negatively impacts treatment delivery and clinical outcomes. In the era of increased prevalence of overweight and obesity among cancer patients, it is difficult to determine the level of pretreatment weight or amount of unintentional weight loss that predicts malnutrition risk. Simple weight loss may not be a reliable predictor of need for nutrition intervention. In this pilot study, a validated malnutrition screening survey, Short Form Patient Generated Subjective Global Assessment (SF-PGSA), was completed by head and neck cancer patients undergoing radiation therapy at Roswell Park Comprehensive Cancer Center at the beginning and at the end of treatment. Change in muscle status for a sample of radiation treated head and neck cancer patients was also estimated using clinically available computed tomography (CT) scans. Patients suffered declines in both malnutrition risk and muscle mass from the beginning of treatment to the end of treatment (approximately 7 weeks) regardless of weight status. Changes in malnutrition risk by last treatment indicated a critical need for nutrition intervention and symptom management, yet most patients did not see a registered dietitian nutritionist. Results align with others reported in the literature indicating a need for change in nutrition and dietetic practice in outpatient oncology. 

CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.1.2, 10.3.2, 8.2.4

Learning Objectives

  1. Describe the short- and long-term outcomes associated with poor nutritional status among head and neck cancer patients undergoing radiation therapy
  2. Discuss the differences between cancer related malnutrition, sarcopenia, and cachexia among cancer patients
  3. Identify potential preventive and management strategies for cancer related malnutrition


Mary Platek, PhD, MS, RD, CDN
D'Youville College
Roswell Park Comprehensive Cancer Center

BMT Subunit Talk: Bridging Research in Clinical Practice

This presentation will focus on the clinical RDN's role in research and, specifically, how to bridge research and clinical practice. Utilizing examples of the emerging evidence for the role of EN in the HCT population, diet recommendations for the neutropenic/immunosuppressed patients, impact of lean body mass on outcomes and metabolic syndrome as a Survivorship topic in the HCT population, this presentation will show that research can be done while practicing clinically and provides great value.

CPEU: 1.0
CPE Level: 3
Performance Indicators: 6.1.6, 6.2.1, 7.4.5

Learning Objectives

  1. Describe various research methodologies and identify how to utilize the latest research to inform best practices as a clinical RDN.
  2. Describe approaches to implement RDN led research and/or partner in multi-disciplinary research in a clinical oncology setting.
  3. Formulate ideas for a Quality Improvement/Quality Assessment project in current area of practice.


Kerry McMillen, MS, RD, CSO, FAND
Fred Hutchinson Cancer Center

RDN Impact on Oncology Outcomes: Findings from a Feasibility Study

Our overall goal is to discuss how care from a Registered Dietitian Nutritionist (RDN) can potentially improve treatment and medical outcomes for cancer patients in the outpatient setting. 

CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.1.2, 10.1.3, 3.3.1

Learning Objectives

  1. Describe what is currently known about the need for dietitians and impact of nutrition care on oncology outcomes in the oncology outpatient setting.
  2. Compare and contrast malnutrition screening and referral practices across outpatient oncology clinics.
  3. Evaluate the results of a feasibility study examining the impact of nutrition care from a dietitian on treatment and medical outcomes for patients in the oncology outpatient setting.


Tricia Cox, MS, RD, CNSC, LD
Baylor Scott
White Health

Dolores Guest, PhD, RD
University of New Mexico

Pediatric Subunit Talk: Modifying Dietary Intake to Impact Pediatric Leukemia Outcomes

Through a biopsychosocial and culturally humble lens:

  • Background -- review the key findings and factors that led to the conception for the IDEAL I trial.
  • Methods -- review the key aspects of the study, including an in-depth review of the diet intervention
  • Results -- present the key results of the statistical and dietary analyses
  • Discussion -- review implications of the study results and the pros, cons, opportunities, and challenges of implementing a dietary intervention in this patient population.
  • Limitations -- acknowledge various limitations of this pilot study
  • Future Direction -- present initial information on the next steps for this work
  • Questions 

CPEU: 1.0
CPE Level: 3
Performance Indicators: 10.3.1, 8.1.1, 8.2.4

Learning Objectives

  1. Attendees will increase their understanding of adverse outcomes associated with overweight and obesity in pediatric ALL.
  2. Attendees will be able to describe the key components of the study dietary intervention.
  3. Attendees will consider the challenges and opportunities of using strict dietary interventions during induction chemotherapy in pediatric patients with ALL.


Celia Framson, MPH, RD, CSP
Children's Hospital Los Angeles

Release Date: June 10, 2022


Check Out Our Current Sales

From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.